ErbB2 growth factor receptor, a marker for neuroendocrine cells?

Area of Science:

• Oncology
• Molecular Biology
• Neuroendocrinology

Background:

• ErbB2 (human epidermal growth factor receptor 2) overexpression in pancreatic cancer varies widely (1-80%).
• Routine examination revealed consistent ErbB2 immunoreactivity in pancreatic islets and intrapancreatic ganglia.
• This discrepancy prompted further investigation into ErbB2 expression patterns.

Purpose of the Study:

• To validate findings of ErbB2 expression in normal pancreatic tissues.
• To understand variations in ErbB2 overexpression frequency in pancreatic cancer.
• To explore the role of ErbB2 in neuroendocrine tissues.

Main Methods:

• Immunohistochemical examination of human tissue samples (normal pancreas, pancreatitis, pancreatic cancer, islet cell tumors).
• Analysis of cultured human islet and cancer cell lines, gastrointestinal tract, CNS, and adrenal gland tissues.
• Western blot and Northern slot-blot analyses for verification.

Main Results:

• Pancreatic cancer cells exhibited heterogeneous ErbB2 immunostaining (in vitro and in vivo).
• Consistent strong ErbB2 immunostaining was observed in human and hamster Langerhans' islets and nerve ganglia.
• Strong ErbB2 expression was also noted in the CNS, spinal cord, and adrenal gland.

Conclusions:

• ErbB2 is crucial in neuroendocrine tissues, influencing cell development and regulation.
• Concomitant ErbB2 expression with islet cell hormones may activate growth pathways in pancreatic cancer.
• This suggests a role for ErbB2 in the aggressive behavior of pancreatic cancer.